Tag Archives: Inovalon

Inovalon Receives a Sell from Morgan Stanley

According to The Fly, morgan Stanley analyst Zachary Sopcak reiterated a Sell rating on Inovalon (NASDAQ: INOV) today and set a price target of $16. The company’s shares opened today at $17.20, close to its 52-week low of $15.12. According

The CEO & Chairman of the Board of Inovalon (NASDAQ: INOV) is Buying Shares

Today, the CEO & Chairman of the Board of Inovalon (NASDAQ: INOV), Keith Dunleavy, bought shares of INOV for $500.4k. Keith Dunleavy increased his holding by 129.61%. Based on Inovalon`s latest earnings report from December 31, the company posted quarterly

Inovalon Receives an Outperform from William Blair

William Blair analyst Ryan Daniels maintained an Outperform rating on Inovalon (NASDAQ: INOV) yesterday. The company’s shares closed yesterday at $17.32, close to its 52-week low of $16.52. Daniels said, “Revising Estimates Following Further Disclosure on Avalere Acquisition We are

William Blair Maintains an Outperform Rating on Inovalon

In a report released today, Ryan Daniels from William Blair maintained an Outperform rating on Inovalon (NASDAQ: INOV). The company’s shares opened today at $21.11. Daniels observed, “Announces Acquisition of Avalere; Accelerated Expansion Into Pharma and Life Sciences Industry Monday

Goldman Sachs Thinks Inovalon’s Stock is Going to Recover

Goldman Sachs analyst Andre Benjamin upgraded Inovalon (NASDAQ: INOV) to Buy today and set a price target of $31. The company’s shares closed yesterday at $23.95, close to its 52-week low of $22.06. Inovalon has an analyst consensus of Moderate